These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29200757)

  • 1. Randomized Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy with Short-Pulsed 1,064-nm Neodymium-Doped Yttrium Aluminium Garnet Laser and Amorolfine Nail Lacquer for Onychomycosis.
    Park KY; Suh JH; Kim BJ; Kim MN; Hong CK
    Ann Dermatol; 2017 Dec; 29(6):699-705. PubMed ID: 29200757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial comparing long-pulsed 1064-Nm neodymium: Yttrium-aluminum-garnet laser alone, topical amorolfine nail lacquer alone, and a combination for nondermatophyte onychomycosis treatment.
    Bunyaratavej S; Wanitphakdeedecha R; Ungaksornpairote C; Kobwanthanakun W; Chanyachailert P; Nokdhes YN; Patthamalai P; Tantrapornpong P; Suphatsathienkul P; Kiratiwongwan R; Limphoka P; Leeyaphan C
    J Cosmet Dermatol; 2020 Sep; 19(9):2333-2338. PubMed ID: 31925917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy for onychomycosis using a fractional 2940-nm Er:YAG laser and 5 % amorolfine lacquer.
    Zhang J; Lu S; Huang H; Li X; Cai W; Ma J; Xi L
    Lasers Med Sci; 2016 Sep; 31(7):1391-6. PubMed ID: 27339057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a fractional 2940-nm Er:YAG laser and 5% amorolfine lacquer combination therapy versus a 5% amorolfine lacquer monotherapy for the treatment of onychomycosis: a randomized controlled trial.
    Zhang J; Zhang Y; Qin J; Lu S; Cai W; Li J; Huang H; Yang S; Xi L
    Lasers Med Sci; 2021 Feb; 36(1):147-152. PubMed ID: 32557000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis.
    Bunyaratavej S; Leeyaphan C; Rujitharanawong C; Surawan TM; Muanprasat C; Matthapan L
    J Dermatolog Treat; 2016 Aug; 27(4):359-63. PubMed ID: 26471716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
    Feng X; Xiong X; Ran Y
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28097731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.
    Blume-Peytavi U; Tosti A; Falqués M; Tamarit ML; Carreño C; Galván J; Tebbs V
    Mycoses; 2022 Apr; 65(4):392-401. PubMed ID: 34752667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
    Schaller M; Sigurgeirsson B; Sarkany M
    Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised comparative study of 1064 nm Neodymium-doped yttrium aluminium garnet (Nd:YAG) laser and topical antifungal treatment of onychomycosis.
    Kim TI; Shin MK; Jeong KH; Suh DH; Lee SJ; Oh IH; Lee MH
    Mycoses; 2016 Dec; 59(12):803-810. PubMed ID: 27402466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosis.
    Paul C; Coustou D; Lahfa M; Bulai-Livideanu C; Doss N; Mokthar I; Turki H; Nouira R; Fazaa B; Ben Osman A; Zourabichvili O; Cazeau C; Coubetergues H; Picot S; Bienvenu AL; Voisard JJ
    Dermatology; 2013; 227(2):157-64. PubMed ID: 24051622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly.
    Reinel D; Clarke C
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():44-9. PubMed ID: 1458665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK; Fleckman P; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
    Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD
    Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of laser therapy combined with topical antifungal agents for onychomycosis: a systematic review and meta-analysis of randomised controlled trials.
    Zhang J; Lin P; Li J; Guo C; Zhai J; Zhang Y
    Lasers Med Sci; 2022 Aug; 37(6):2557-2569. PubMed ID: 35484440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized, Double-blind Study of Amorolfine 5% Nail Lacquer with Oral Fluconazole Compared with Oral Fluconazole Alone in the Treatment of Fingernail Onychomycosis.
    Chandra S; Sancheti K; Podder I; Das A; Sarkar TK; Chowdhury M; Sil A; Bhattacharya S; Das NK
    Indian J Dermatol; 2019; 64(4):253-260. PubMed ID: 31516132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of the Er:YAG 2940nm laser associated with amorolfine lacquer in the treatment of onychomycosis.
    Morais OO; Costa IM; Gomes CM; Shinzato DH; Ayres GM; Cardoso RM
    An Bras Dermatol; 2013; 88(5):847-9. PubMed ID: 24173203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predisposing factors, clinical features and treatment outcomes of Fusarium onychomycosis and comparison of its characteristics with Neoscytalidium onychomycosis.
    Phaitoonwattanakij S; Leeyaphan C; Lertrujiwanit K; Bunyaratavej S
    J Mycol Med; 2021 Sep; 31(3):101165. PubMed ID: 34171603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of onychomycosis using a submillisecond 1064-nm neodymium:yttrium-aluminum-garnet laser.
    Carney C; Cantrell W; Warner J; Elewski B
    J Am Acad Dermatol; 2013 Oct; 69(4):578-82. PubMed ID: 23856649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.